RAVENSBERG GMBH CHEM FAB has a total of 11 patent applications. Its first patent ever was published in 1955. It filed its patents most often in Germany, Switzerland and Denmark. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and consumer goods are LOEVENS KEMISKE FAB, RIPARI GERO IST FARM BIOLOG and WUELFING J A FA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 6 | |
#2 | Switzerland | 3 | |
#3 | Denmark | 1 | |
#4 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Consumer goods |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Tobacco | |
#5 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Siemer Harm Dr | 3 |
#2 | Doppstadt Adolf Dr | 3 |
#3 | Doppstadt Dr Adolf | 2 |
#4 | Gegner Dr Eberhard | 2 |
#5 | Hans C Dr Stark | 1 |
#6 | Abel Dieter Dipl Chem Dr | 1 |
#7 | Stark Hans Carl | 1 |
#8 | Danner | 1 |
#9 | Doppstadt A | 1 |
#10 | Carl Dr Stark Hans | 1 |
Publication | Filing date | Title |
---|---|---|
DE2609923A1 | (3)-Thienyl-(3)-phenyl-(3)-hydroxy-propyl morpholine prepn. - from phenyl-morpholino-propanone and thiophene lithium | |
DE1904466A1 | N,n'-bis-nicotinyloxyalkylpiperazines for - the treatment of coronary illness and | |
DE1768903B1 | Process for the preparation of the neutral salt from 2,6-di-tert-butyl-naphthalene-disulfonic acid and l - (-) - 1,2-diphenyl-3-methyl-4-dimethyl-aminobutyl- (2) -propionic acid ester |